SlideShare a Scribd company logo
1 of 21
It is the metabolic alteration of drug molecules . This
usually involves two types of biochemical reactions
that occur sequentially in two phases known as phase
(ǀ) and phase (ǁ). Phase I reactions usually involves
oxidation ,reduction ,hydrolysis , deamination and
dealkylation reactions. This may render the
descendant drug more active and some times more
toxic than the parent drug (functionalization phase).
Amna Medani , 2015
Phase II reactions involve conjugation reactions which render the
drug inactive . Both stages will decrease the lipid solubility of the
drug and hence , Increase its renal elemination assissted by the non-
selective detoxification system of the intracellular metabolizing
enzymes.
This takes place mainly in the liver except for some drugs where
the two phases occur in the plasma (e.g. hydrolysis of
suxamethonium and procaine by plasma cholinesterases) , in the
lung (e.g. various prostanoids) or in the wall of intestines (e.g.
tryptamines ).
Amna Medani , 2015
The liver intracellular enzymes are mostly attached to
the smooth endoplasmic reticulum (microsomal
enzymes) sediment after prolonged high speed
centrifugation on homogenization. A non-polar drug
,more readily ,can pass the hepatocyte membrane and
reach these enzymes where as the highly polar drugs ,
if they do not have a carrier system , may be excreted
unchanged.
Amna Medani , 2015
Phase I Reactions
A/ Oxidation Reactions :
(Hydroxylation of nitrogen and carbon atoms , N- and O-
dealkylation and oxidative deamination) are catalyzed by
the enzymatic system mixed function oxygenase system
that resides on the endoplasmic reticulum ( e.g.
cytochrome P-450 that catalyze hydroxylation reactions)
.
Amna Medani , 2015
Some drugs may be metabolized by:
I / The soluble cytoplasm enzyme alcohol
dehydrogenase (e.g. ethanol) .
II/ The non-microsomal enzyme xanthine oxidase
(involoved in uric acid synthesis and inactivation of the
cytotoxic drug 6-mercaptopurine).
III/The monoamine oxidase enzyme ( involved in the
inactivation of many active amines e.g. tyramine and
noradrenaline ) which can occur in many tissues other
than the liver.
Amna Medani , 2015
B/ Reduction Reactions:
I/ The anticoagulant drug warfarin is inactivated by the
conversion of a ketone group to a hydoxyl one .
II/ Many steroids (e.g. cortisone and prednisone) are
activated by the reduction of the ketone group to the
corrosponding hydroxy compounds. These also
involves microsomal enzymes .
Amna Medani , 2015
C/ Hydrolytic Reactions:
These occur only in tissues other than the liver to
hydrolyse the ester and amide groups (e.g. hydrolysis of
procaine by the plasma cholinesterases).
Amna Medani , 2015
Phase II Reactions
A drug may be susceptible to a conjugation reaction (
attachment of a substituent group), if it has a handling
group (e.g. a hydoxyl , a thiol or an aminogroup) . The
conjugate is pharmacologically inactive and less lipid
soluble than the precursor ( from phase I ) is then
excreted. This conjugate formation is often involoving a
glucuroynly- , a glycyl- , a sulphate- , a methyl- , an
acetyl- or a glutamyl- group in the liver ,mostly , lung or
kidney .
Amna Medani , 2015
I/Glucronide formation involves the formation of a
high energy phosphate group (Uridine Diphospho-
Glucuronic Acid ) from which the acid part is
changed into an electron rich atom ( N-,O- OR S- )
forming and amide- , ester or thiol- bonds catalyzed
by glucuronyl-transferase.
II/ Acetylatin and methylation reactions occur with
acetyl co-A and S-adenosyl methionine respectively.
Amna Medani , 2015
Induction of Microsomal Enzymes:
Many drugs can enhance the activity of microsomal enzymes
and the conjugateing system (e.g. ethanol,phenobarbitone and
phenylbutazone) as well as some carcinogenic substances
(e.g. benzpyrine ) . This can result from an increase of :
I/ Microsomal enzymes synthesis.
II/ The rate of metabolism of inducing agent in variable
patterns (e.g. phenobarbitone is a verstile , non-selective
inducer that increase the rate of degradation of many drugs
and polycyclic hydrocarbons are selective only to oxidase
enzyme ). Induction to phase I metabolism can increase the
drug effect.Phase I induced metabolites may cause toxicity (
e.g. paracetamol and the carcinogenic polcyclic
hydrocarbons).
Amna Medani , 2015
Mechanism:
This is suspected to involve stimulation of gene
transcription leading to incearsed protien synthesis
by binding to cytosolic recteptor that in turn binds to
to specific DNA sequences associated with the
production of particular drug metabolizing enzymes.
First-pass metabolism ( Presystemic ):
-Much larger dose of the drug is required orally.
-Marked individual variation occur in the extend to
which a drug can be metabolized.
Amna Medani , 2015
Renal Excretion of Drugs & Drug Metabolites
-The kidneys handle different dugs differently (e.g.
penicillin is excreted completely after a single passage
through the kidney , where as the chlorpromazine is
excreted slowly and all the drugs excretion rates fall
between these two ranges).
-The products of phases I and II are excreted more
readily than the parent drug.
Amna Medani , 2015
-The basic processes incorporated in renal excretion
are :
I/ Glumerular Filteration :
- This allows all drugs of molecular weight less than
20000 with a concentraction in the filtrate nearly
similar to that in plasma.Drugs bound to plasma
protiens ( plasma albumin molecular weight =
68000) are less readily found in the filterate (e.g.
phenylbutazone concentrations is 98% bound to
plasma albumin and its concentration in the filtrate is
2% only )
Amna Medani , 2015
II/ Tubular Secretion & Reabsorption:
-20% of a drug is removed from blood via glumerular
filtration ,whereas the remainder 80% moves to the
pretubular capillaries of the proximal tubules to reach the two
independent , non-selective carrier systems ( one can transport
acidic drug and the other is specific for basic substances) to
be taken to the tubular lumen against an electrochemical
gradient
-Many drugs excreted via kidneys share the same carrier
system and hence , compitition occur ( e.g. probencid retard
the excretion of penicillin and inhibit the reabsorption of uric
acid , but it is useful in the treatment of gout ).
Amna Medani , 2015
III/ Diffusion Across Renal Tubules:
-Water is reabsorbed in the renal tubules ( urine
volume is 1% of that of the filtrate).drugs with
micromolecules are readily filtered in the renal
tubules( plasma concentration – filtrate
concentration) and hence , it can easily be
absorbed passively.Drugs with high lipid
solubility and high tubular permeability are also
slowly excreted.
Amna Medani , 2015
-Highly polar drugs have high urine
concentrations (e.g. gallamine and streptomycin).
-Weak acids and bases change their ionization
and hence, markedly affect excretion ( a basic
drug may be readily excreted in an acidic urine (
e.g. gaptamine )and an acidic drug can not be
reabsorped if the urine is alkaline ( e.g.
barbiturate and aspirin) due to ionization.
Amna Medani , 2015
Drug Clearance :
It is the volume of plasma containing the amount of substance that is
removed by the kidney in a unit time :
CLr = CU VU/CP
Where :
CLr = Clearance of a drug.
Cu = Drug urinary concentration.
Vu = Rate of flow of urine.
Cp = Drug plasma concentration.
Amna Medani , 2015
Factors Affecting Drug Clearance :
-Drugs that are completely filtered (not protien-bound)
may have a clearance almost similar to the glumerular
filteration (e.g. insulin CLr = 120 ml / min. ).
-Drugs that are completely excreted via the carrier
system of the renal tubule during a single passage
through the kidney (e.g. penicillin ) ,may have a CLr
nearly equal to that of P-amiohippuric acid which is
equal to renal plasma flow (700 ml/min. ).
Amna Medani , 2015
-Drugs that are excreted via passive
diffusion (e.g. barbiturates) may have a
CLr nearly equal to the rate of urine
formation (1ml / min. ).
-Clearance varies among individuals and
from time to time in the same individual
thus, affecting the values of drug safety.
Amna Medani , 2015
Billiary Excretion :
The transference of drugs and drug metabolites from
plasma to bile through liver cells.
TRANSPORT SYSTEMS:
I/ Acid and base handling systems.
II/ Transport of unchanged molecules.
Amna Medani , 2015
-Various hydrophilic drugs conjugates are delivered
into the intestines , hydrolized and then released to
be reabsorbed and recycled again ( e.g. digoxin,
morphine ,chloramphenicol and stilbosterol).
- Some drugs are considerably excreted in bile (e.g.
cromoglycate in the unchanged form and rifambicin
in the deacetylated form).
Amna Medani , 2015

More Related Content

What's hot

Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugswonderingsoul114
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugsNaresh Gorantla
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptxGitanjaliMehetre1
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugsRajat Mahamana
 
Mechanism of drug absorption in git
Mechanism of drug absorption in gitMechanism of drug absorption in git
Mechanism of drug absorption in gitAnjita Khadka
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsFarazaJaved
 
Absorption of drugs ,,,,,,,,
Absorption of drugs ,,,,,,,,Absorption of drugs ,,,,,,,,
Absorption of drugs ,,,,,,,,Viraj Shinde
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretionamina tariq
 
Physicochemical properties of drug
Physicochemical properties of drugPhysicochemical properties of drug
Physicochemical properties of drugkhushbu
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.pptramchoure90
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionchiranjibi68
 
Drug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsDrug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsHeena Parveen
 
Drug metabolism Phase II reaction
Drug metabolism Phase II reactionDrug metabolism Phase II reaction
Drug metabolism Phase II reactionDrParthiban1
 

What's hot (20)

Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Excretion of drug
Excretion of drugExcretion of drug
Excretion of drug
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Drug excretion
Drug excretionDrug excretion
Drug excretion
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
 
Phase ii biotransform of drugs
Phase ii biotransform of drugsPhase ii biotransform of drugs
Phase ii biotransform of drugs
 
Excretion of drug (VK)
Excretion of drug (VK)Excretion of drug (VK)
Excretion of drug (VK)
 
Drug metabolism
Drug metabolism Drug metabolism
Drug metabolism
 
Mechanism of drug absorption in git
Mechanism of drug absorption in gitMechanism of drug absorption in git
Mechanism of drug absorption in git
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugs
 
Absorption of drugs ,,,,,,,,
Absorption of drugs ,,,,,,,,Absorption of drugs ,,,,,,,,
Absorption of drugs ,,,,,,,,
 
Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretion
 
Physicochemical properties of drug
Physicochemical properties of drugPhysicochemical properties of drug
Physicochemical properties of drug
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Drug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsDrug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugs
 
Drug metabolism Phase II reaction
Drug metabolism Phase II reactionDrug metabolism Phase II reaction
Drug metabolism Phase II reaction
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 

Similar to Drug metabolism

metabolism and elemination.ppt
metabolism and elemination.pptmetabolism and elemination.ppt
metabolism and elemination.pptMamtanaagar1
 
pharmacokinetics and pharmacodynamics
pharmacokinetics and pharmacodynamicspharmacokinetics and pharmacodynamics
pharmacokinetics and pharmacodynamicsKrishnaDeshpande9
 
Biotransformation or metabolism of drugs
Biotransformation or metabolism of drugsBiotransformation or metabolism of drugs
Biotransformation or metabolism of drugsDr.Dhananjay Singh
 
pharmacokinetics pdf slideshare
pharmacokinetics pdf slidesharepharmacokinetics pdf slideshare
pharmacokinetics pdf slidesharehamzashahzad28
 
Induction and Inhibition of Drug Metabolism Inhibition of Biliary Excretion
Induction and Inhibition of Drug Metabolism Inhibition of Biliary ExcretionInduction and Inhibition of Drug Metabolism Inhibition of Biliary Excretion
Induction and Inhibition of Drug Metabolism Inhibition of Biliary ExcretionDr B Naga Raju
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlespooranachithra flowry
 
Class excretion of drugs
Class excretion of drugsClass excretion of drugs
Class excretion of drugsRaghu Prasada
 
biotransformation
 biotransformation  biotransformation
biotransformation zeelmevada
 
Drug Metabolism.pdf
Drug Metabolism.pdfDrug Metabolism.pdf
Drug Metabolism.pdfAman134123
 
introduction to pharmacokinetic and pharmacodynamic principles
introduction to pharmacokinetic and pharmacodynamic principlesintroduction to pharmacokinetic and pharmacodynamic principles
introduction to pharmacokinetic and pharmacodynamic principlesDr. Maria Qammar
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptxchetanadakhare
 
pharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdfpharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdfsafa98
 
Pharmacokinetics ii
Pharmacokinetics  iiPharmacokinetics  ii
Pharmacokinetics iiDr. Pooja
 
Pharmacokinetics Drug drug interaction [Best one]
Pharmacokinetics Drug drug interaction [Best one]Pharmacokinetics Drug drug interaction [Best one]
Pharmacokinetics Drug drug interaction [Best one]abdelrahman_asar
 

Similar to Drug metabolism (20)

metabolism and elemination.ppt
metabolism and elemination.pptmetabolism and elemination.ppt
metabolism and elemination.ppt
 
Drug Metabolism.pptx
Drug Metabolism.pptxDrug Metabolism.pptx
Drug Metabolism.pptx
 
pharmacokinetics and pharmacodynamics
pharmacokinetics and pharmacodynamicspharmacokinetics and pharmacodynamics
pharmacokinetics and pharmacodynamics
 
Biotransformation or metabolism of drugs
Biotransformation or metabolism of drugsBiotransformation or metabolism of drugs
Biotransformation or metabolism of drugs
 
pharmacokinetics pdf slideshare
pharmacokinetics pdf slidesharepharmacokinetics pdf slideshare
pharmacokinetics pdf slideshare
 
Induction and Inhibition of Drug Metabolism Inhibition of Biliary Excretion
Induction and Inhibition of Drug Metabolism Inhibition of Biliary ExcretionInduction and Inhibition of Drug Metabolism Inhibition of Biliary Excretion
Induction and Inhibition of Drug Metabolism Inhibition of Biliary Excretion
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principles
 
Class excretion of drugs
Class excretion of drugsClass excretion of drugs
Class excretion of drugs
 
biotransformation
 biotransformation  biotransformation
biotransformation
 
Metabolism
MetabolismMetabolism
Metabolism
 
Drug Metabolism.pdf
Drug Metabolism.pdfDrug Metabolism.pdf
Drug Metabolism.pdf
 
Drug interaction
Drug interactionDrug interaction
Drug interaction
 
introduction to pharmacokinetic and pharmacodynamic principles
introduction to pharmacokinetic and pharmacodynamic principlesintroduction to pharmacokinetic and pharmacodynamic principles
introduction to pharmacokinetic and pharmacodynamic principles
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptx
 
pharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdfpharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdf
 
Pharmacokinetics ii
Pharmacokinetics  iiPharmacokinetics  ii
Pharmacokinetics ii
 
Drug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug InteractionsDrug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug Interactions
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetics Drug drug interaction [Best one]
Pharmacokinetics Drug drug interaction [Best one]Pharmacokinetics Drug drug interaction [Best one]
Pharmacokinetics Drug drug interaction [Best one]
 

More from Amna Medani

appointment as associate
appointment as associateappointment as associate
appointment as associateAmna Medani
 
ATTACHAE CV September 2016
ATTACHAE  CV September 2016ATTACHAE  CV September 2016
ATTACHAE CV September 2016Amna Medani
 
TEACHING AND CIRRICULUM DESIGN EXPERIENCE,Sept.2016
TEACHING AND CIRRICULUM DESIGN  EXPERIENCE,Sept.2016TEACHING AND CIRRICULUM DESIGN  EXPERIENCE,Sept.2016
TEACHING AND CIRRICULUM DESIGN EXPERIENCE,Sept.2016Amna Medani
 
Pharmacodynamics.doc
Pharmacodynamics.docPharmacodynamics.doc
Pharmacodynamics.docAmna Medani
 
Molecular Aspects of Drug Action
Molecular Aspects of Drug ActionMolecular Aspects of Drug Action
Molecular Aspects of Drug ActionAmna Medani
 
Basic principles of chemotherapy
Basic principles of chemotherapyBasic principles of chemotherapy
Basic principles of chemotherapyAmna Medani
 
Principles of Toxicology for Dietetics
Principles of Toxicology for DieteticsPrinciples of Toxicology for Dietetics
Principles of Toxicology for DieteticsAmna Medani
 
Pharmacodynamics.doc
Pharmacodynamics.docPharmacodynamics.doc
Pharmacodynamics.docAmna Medani
 
Molecular aspects of drug action
Molecular aspects of drug actionMolecular aspects of drug action
Molecular aspects of drug actionAmna Medani
 
Drug distribution
Drug distributionDrug distribution
Drug distributionAmna Medani
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administrationAmna Medani
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacologyAmna Medani
 
Basic principles of chemotherapy
Basic principles of chemotherapyBasic principles of chemotherapy
Basic principles of chemotherapyAmna Medani
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicologyAmna Medani
 
Essential Outlines on Drug Interactions for Dental Practice
Essential Outlines on Drug Interactions for Dental PracticeEssential Outlines on Drug Interactions for Dental Practice
Essential Outlines on Drug Interactions for Dental PracticeAmna Medani
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacologyAmna Medani
 
Drugs affecting blood
Drugs affecting bloodDrugs affecting blood
Drugs affecting bloodAmna Medani
 

More from Amna Medani (20)

appointment as associate
appointment as associateappointment as associate
appointment as associate
 
ATTACHAE CV September 2016
ATTACHAE  CV September 2016ATTACHAE  CV September 2016
ATTACHAE CV September 2016
 
TEACHING AND CIRRICULUM DESIGN EXPERIENCE,Sept.2016
TEACHING AND CIRRICULUM DESIGN  EXPERIENCE,Sept.2016TEACHING AND CIRRICULUM DESIGN  EXPERIENCE,Sept.2016
TEACHING AND CIRRICULUM DESIGN EXPERIENCE,Sept.2016
 
The heart
The heartThe heart
The heart
 
Pharmacodynamics.doc
Pharmacodynamics.docPharmacodynamics.doc
Pharmacodynamics.doc
 
Molecular Aspects of Drug Action
Molecular Aspects of Drug ActionMolecular Aspects of Drug Action
Molecular Aspects of Drug Action
 
Basic principles of chemotherapy
Basic principles of chemotherapyBasic principles of chemotherapy
Basic principles of chemotherapy
 
Principles of Toxicology for Dietetics
Principles of Toxicology for DieteticsPrinciples of Toxicology for Dietetics
Principles of Toxicology for Dietetics
 
Pharmacodynamics.doc
Pharmacodynamics.docPharmacodynamics.doc
Pharmacodynamics.doc
 
Molecular aspects of drug action
Molecular aspects of drug actionMolecular aspects of drug action
Molecular aspects of drug action
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Drug Absorption
Drug  AbsorptionDrug  Absorption
Drug Absorption
 
Membranes
MembranesMembranes
Membranes
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Basic principles of chemotherapy
Basic principles of chemotherapyBasic principles of chemotherapy
Basic principles of chemotherapy
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
 
Essential Outlines on Drug Interactions for Dental Practice
Essential Outlines on Drug Interactions for Dental PracticeEssential Outlines on Drug Interactions for Dental Practice
Essential Outlines on Drug Interactions for Dental Practice
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Drugs affecting blood
Drugs affecting bloodDrugs affecting blood
Drugs affecting blood
 

Recently uploaded

How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxleah joy valeriano
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 

Recently uploaded (20)

How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 

Drug metabolism

  • 1. It is the metabolic alteration of drug molecules . This usually involves two types of biochemical reactions that occur sequentially in two phases known as phase (ǀ) and phase (ǁ). Phase I reactions usually involves oxidation ,reduction ,hydrolysis , deamination and dealkylation reactions. This may render the descendant drug more active and some times more toxic than the parent drug (functionalization phase). Amna Medani , 2015
  • 2. Phase II reactions involve conjugation reactions which render the drug inactive . Both stages will decrease the lipid solubility of the drug and hence , Increase its renal elemination assissted by the non- selective detoxification system of the intracellular metabolizing enzymes. This takes place mainly in the liver except for some drugs where the two phases occur in the plasma (e.g. hydrolysis of suxamethonium and procaine by plasma cholinesterases) , in the lung (e.g. various prostanoids) or in the wall of intestines (e.g. tryptamines ). Amna Medani , 2015
  • 3. The liver intracellular enzymes are mostly attached to the smooth endoplasmic reticulum (microsomal enzymes) sediment after prolonged high speed centrifugation on homogenization. A non-polar drug ,more readily ,can pass the hepatocyte membrane and reach these enzymes where as the highly polar drugs , if they do not have a carrier system , may be excreted unchanged. Amna Medani , 2015
  • 4. Phase I Reactions A/ Oxidation Reactions : (Hydroxylation of nitrogen and carbon atoms , N- and O- dealkylation and oxidative deamination) are catalyzed by the enzymatic system mixed function oxygenase system that resides on the endoplasmic reticulum ( e.g. cytochrome P-450 that catalyze hydroxylation reactions) . Amna Medani , 2015
  • 5. Some drugs may be metabolized by: I / The soluble cytoplasm enzyme alcohol dehydrogenase (e.g. ethanol) . II/ The non-microsomal enzyme xanthine oxidase (involoved in uric acid synthesis and inactivation of the cytotoxic drug 6-mercaptopurine). III/The monoamine oxidase enzyme ( involved in the inactivation of many active amines e.g. tyramine and noradrenaline ) which can occur in many tissues other than the liver. Amna Medani , 2015
  • 6. B/ Reduction Reactions: I/ The anticoagulant drug warfarin is inactivated by the conversion of a ketone group to a hydoxyl one . II/ Many steroids (e.g. cortisone and prednisone) are activated by the reduction of the ketone group to the corrosponding hydroxy compounds. These also involves microsomal enzymes . Amna Medani , 2015
  • 7. C/ Hydrolytic Reactions: These occur only in tissues other than the liver to hydrolyse the ester and amide groups (e.g. hydrolysis of procaine by the plasma cholinesterases). Amna Medani , 2015
  • 8. Phase II Reactions A drug may be susceptible to a conjugation reaction ( attachment of a substituent group), if it has a handling group (e.g. a hydoxyl , a thiol or an aminogroup) . The conjugate is pharmacologically inactive and less lipid soluble than the precursor ( from phase I ) is then excreted. This conjugate formation is often involoving a glucuroynly- , a glycyl- , a sulphate- , a methyl- , an acetyl- or a glutamyl- group in the liver ,mostly , lung or kidney . Amna Medani , 2015
  • 9. I/Glucronide formation involves the formation of a high energy phosphate group (Uridine Diphospho- Glucuronic Acid ) from which the acid part is changed into an electron rich atom ( N-,O- OR S- ) forming and amide- , ester or thiol- bonds catalyzed by glucuronyl-transferase. II/ Acetylatin and methylation reactions occur with acetyl co-A and S-adenosyl methionine respectively. Amna Medani , 2015
  • 10. Induction of Microsomal Enzymes: Many drugs can enhance the activity of microsomal enzymes and the conjugateing system (e.g. ethanol,phenobarbitone and phenylbutazone) as well as some carcinogenic substances (e.g. benzpyrine ) . This can result from an increase of : I/ Microsomal enzymes synthesis. II/ The rate of metabolism of inducing agent in variable patterns (e.g. phenobarbitone is a verstile , non-selective inducer that increase the rate of degradation of many drugs and polycyclic hydrocarbons are selective only to oxidase enzyme ). Induction to phase I metabolism can increase the drug effect.Phase I induced metabolites may cause toxicity ( e.g. paracetamol and the carcinogenic polcyclic hydrocarbons). Amna Medani , 2015
  • 11. Mechanism: This is suspected to involve stimulation of gene transcription leading to incearsed protien synthesis by binding to cytosolic recteptor that in turn binds to to specific DNA sequences associated with the production of particular drug metabolizing enzymes. First-pass metabolism ( Presystemic ): -Much larger dose of the drug is required orally. -Marked individual variation occur in the extend to which a drug can be metabolized. Amna Medani , 2015
  • 12. Renal Excretion of Drugs & Drug Metabolites -The kidneys handle different dugs differently (e.g. penicillin is excreted completely after a single passage through the kidney , where as the chlorpromazine is excreted slowly and all the drugs excretion rates fall between these two ranges). -The products of phases I and II are excreted more readily than the parent drug. Amna Medani , 2015
  • 13. -The basic processes incorporated in renal excretion are : I/ Glumerular Filteration : - This allows all drugs of molecular weight less than 20000 with a concentraction in the filtrate nearly similar to that in plasma.Drugs bound to plasma protiens ( plasma albumin molecular weight = 68000) are less readily found in the filterate (e.g. phenylbutazone concentrations is 98% bound to plasma albumin and its concentration in the filtrate is 2% only ) Amna Medani , 2015
  • 14. II/ Tubular Secretion & Reabsorption: -20% of a drug is removed from blood via glumerular filtration ,whereas the remainder 80% moves to the pretubular capillaries of the proximal tubules to reach the two independent , non-selective carrier systems ( one can transport acidic drug and the other is specific for basic substances) to be taken to the tubular lumen against an electrochemical gradient -Many drugs excreted via kidneys share the same carrier system and hence , compitition occur ( e.g. probencid retard the excretion of penicillin and inhibit the reabsorption of uric acid , but it is useful in the treatment of gout ). Amna Medani , 2015
  • 15. III/ Diffusion Across Renal Tubules: -Water is reabsorbed in the renal tubules ( urine volume is 1% of that of the filtrate).drugs with micromolecules are readily filtered in the renal tubules( plasma concentration – filtrate concentration) and hence , it can easily be absorbed passively.Drugs with high lipid solubility and high tubular permeability are also slowly excreted. Amna Medani , 2015
  • 16. -Highly polar drugs have high urine concentrations (e.g. gallamine and streptomycin). -Weak acids and bases change their ionization and hence, markedly affect excretion ( a basic drug may be readily excreted in an acidic urine ( e.g. gaptamine )and an acidic drug can not be reabsorped if the urine is alkaline ( e.g. barbiturate and aspirin) due to ionization. Amna Medani , 2015
  • 17. Drug Clearance : It is the volume of plasma containing the amount of substance that is removed by the kidney in a unit time : CLr = CU VU/CP Where : CLr = Clearance of a drug. Cu = Drug urinary concentration. Vu = Rate of flow of urine. Cp = Drug plasma concentration. Amna Medani , 2015
  • 18. Factors Affecting Drug Clearance : -Drugs that are completely filtered (not protien-bound) may have a clearance almost similar to the glumerular filteration (e.g. insulin CLr = 120 ml / min. ). -Drugs that are completely excreted via the carrier system of the renal tubule during a single passage through the kidney (e.g. penicillin ) ,may have a CLr nearly equal to that of P-amiohippuric acid which is equal to renal plasma flow (700 ml/min. ). Amna Medani , 2015
  • 19. -Drugs that are excreted via passive diffusion (e.g. barbiturates) may have a CLr nearly equal to the rate of urine formation (1ml / min. ). -Clearance varies among individuals and from time to time in the same individual thus, affecting the values of drug safety. Amna Medani , 2015
  • 20. Billiary Excretion : The transference of drugs and drug metabolites from plasma to bile through liver cells. TRANSPORT SYSTEMS: I/ Acid and base handling systems. II/ Transport of unchanged molecules. Amna Medani , 2015
  • 21. -Various hydrophilic drugs conjugates are delivered into the intestines , hydrolized and then released to be reabsorbed and recycled again ( e.g. digoxin, morphine ,chloramphenicol and stilbosterol). - Some drugs are considerably excreted in bile (e.g. cromoglycate in the unchanged form and rifambicin in the deacetylated form). Amna Medani , 2015